Skip to main content
SpringerLink
Log in

Corticotropin- and growth hormone-releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases

  • Trends in pituitary surgery
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Summary

The recently discovered releasing factors for ACTH and growth hormone, CRF and GRF, have stimulated our understanding of the hypothalamo-pituitary physiology and pathophysiology. Whereas CRF, a 41 amino-acid residue peptide, seems to be a useful additional tool in the differential diagnosis of Cushing's syndrome, GRF, a 44 amino-acid residue peptide, seems to be of little value in the diagnosis of active acromegaly. However, both releasing factors are useful in the follow-up of these two hypersecretory diseases after neurosurgical treatment. In addition, the measurement of CRF and GRF activity by radioimmunoassay in the peripheral circulation will be of great importance in making the diagnosis of ectopic CRF- and GRF-secretion, syndromes which have been appreciated only in recent years.

Furthermore, CRF and GRF-stimulation tests are useful in elucidating the cause of anterior pituitary failure and GRF may be of benefit for the treatment of pituitary dwarfism. However, it has to be stressed that the results of the new CRF and GRF tests can only be interpreted together with results of other established pituitary function tests and the neuroradiological evaluation of the hypothalamo-pituitary area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Borges, J. L. C., R. M. Blizzard, W. S. Evans, R. Furlanetto, A. D. Rogol, D. L. Kaiser, J. Rivier, W. Vale, M. O. Thorner: Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumour GH-releasing factor. J. Clin. Endocrinol. Metab. 59 (1984) 1–6

    PubMed  Google Scholar 

  2. Carey, R. M., S. K. Varma, C. R. Drake, M. O. Thorner, K. Kovacs, J. Rivier, W. Vale: Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. N. Engl. J. Med. 311 (1984) 13–20

    PubMed  Google Scholar 

  3. Chrousos, G. P., H. M. Schulte, E. H. Oldfield, P. W. Gold, G. B. Cutler, D. L. Loriaux: The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N. Engl. J. Med. 310 (1984) 623–626

    Google Scholar 

  4. DeBold, C. R., G. S. DeCherney, R. V. Jackson, W. R. Sheldon, A. N. Alexander, D. P. Island, J. Rivier, W. Vale, D. N. Orth: Effect of synthetic ovine corticotropin-releasing factor: Prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol. J. Clin. Endocrinol. Metab. 57 (1983) 294–298

    PubMed  Google Scholar 

  5. Frohman, L. A.: Production of growth hormone releasing factor by tumours. 7th International Congress of Endocrinology, July 1–7, Quebec City. Excerpta Medica, Amsterdam, International Congress Series 652 (1984) 16

    Google Scholar 

  6. Frohman, L. A., J. L. Thominet, C. B. Webb, M. L. Vance, H. Uderman, J. Rivier, W. Vale, M. O. Thorner: Metabolic clearance and plasma disappearance rates of human pancreatic tumour growth hormone releasing factor in man. J. Clin. Invest. 73 (1984) 1304–1311

    PubMed  Google Scholar 

  7. Grossman, A., N. Lytras, M. O. Savage, J. A. H. Wass, D. H. Coy, L. H. Rees, A. E. Jones, G. M. Besser: Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. Br. Med. J. 288 (1984) 1785–1787

    Google Scholar 

  8. Grosman, A., L. Perry, A. V. Schally, L. H. Rees, A. C. Nieuwenhuyzen-Kruseman, S. Tomlin, D. H. Coy, A. M. Comaru-Schally, G. M. Besser: New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man. Lancet 1 (1982) 921–922

    PubMed  Google Scholar 

  9. Guillemin, R., N. Ling, F. Esch, P. Böhlen, P. Brazeau, W. Wehrenberg, A. Baird, B. Bloch, C. Mougin, F. Zeytin: Growth hormone-releasing factor. An update. 7th International Congress of Endocrinology, July 1–7, Quebec City. Excerpta Medica, Amsterdam, International Congress Series 652 (1984) 179

    Google Scholar 

  10. Guillemin, R., P. Brazeau, P. Böhlen, F. Esch, N. Ling, W. B. Wehrenberg: Growth hormone releasing factor from a human pancreatic tumour that caused acromegaly. Science 218 (1982) 585–587

    PubMed  Google Scholar 

  11. Guillemin, R., F. Zeytin, N. Ling, P. Böhlen, F. Esch, P. Brazeau, B. Bloch, W. B. Wehrenberg: Growth hormone-releasing factor: Chemistry and physiology. Proc. Soc. Exp. Biol. Med. 175 (1984) 407–413

    PubMed  Google Scholar 

  12. Harris, G. W.: Neural control of the pituitary. Physiol. Rev. 28 (1948) 139–173

    Google Scholar 

  13. Hermus, A., J. M. M. Raemaekers, G. F. F. M. Pieters, A. K. M. Bartelink, A. G. H. Smals, P. W. C. Kloppenborg: Serious reactions to corticotropin-releasing factor. Lancet 1 (1983) 776

    Google Scholar 

  14. Hermus, A., J. M. M. Raemaekers, G. F. F. M. Pieters, A. K. M. Bartelink, A. G. H. Smals, P. W. C. Kloppenborg: Safety of corticotropin-releasing factor. Lancet 2 (1983) 112

    Google Scholar 

  15. Lamberts, S. W. J., T. Verleun, R. Oosterom, F. de Jong, W. H. L. Hackeng: Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J. Clin. Endocrinol. Metab. 58 (1984) 298–303

    PubMed  Google Scholar 

  16. Lance, V. A., W. A. Murphy, J. Sueiras-Diaz, D. H. Coy: Superactive analogues of growth hormone releasing factor (1–29)-amide. Biochem. Biophys. Res. Commun. 119 (1984) 265–272

    PubMed  Google Scholar 

  17. Liu, J. H., K. Muse, P. Contreras, D. Gibbs, W. Vale, J. Rivier, S. S. C. Yen: Augmentation of ACTH-releasing activity of synthetic corticotropinreleasing factor (CRF) by vasopressin in women. J. Clin. Endocrinol. Metab. 57 (1983) 1087–1089

    PubMed  Google Scholar 

  18. Losa, M., G. K. Stalla, O. A. Müller, K. von Werder: Human pancreatic growth hormone-releasing factor (hpGRF): dose-response of GRF- and GH-levels. Klin. Wochenschr. 61 (1983) 1249–1253

    PubMed  Google Scholar 

  19. Losa, M., G. K. Stalla, O. A. Müller, L. Bock, K. von Werder: GH- and GRF-levels after bolus injection and infusion of hpGRF in normal subjects and patients with acromegaly. Acta Endocrinol. [Suppl.] (Copenh.) 264 (1984) 32

    Google Scholar 

  20. Lytras, N., A. Grossman, L. Perry, S. Tomlin, J. A. H. Wass, D. H. Coy, A. V. Schally, L. H. Rees, G. M. Besser: Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin. Endocrinol. 20 (1984) 71–84

    Google Scholar 

  21. Müller, O. A., H. G. Dörr, B. Hagen, G. K. Stalla, K. von Werder: Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis. Klin. Wochenschr. 60 (1982) 1485–1491

    PubMed  Google Scholar 

  22. Müller, O. A., M. Losa, R. Oeckler, K. von Werder: CRF- and GRF-stimulation tests in patients with hypothalamic disorders. Acta Endocrinol. [Suppl.] (Copenh.) 264 (1984) 33

    Google Scholar 

  23. Müller, O. A., G. K. Stalla, J. Hartwimmer, J. Schopohl, K. von Werder: Corticotropin releasing factor (CRF): Diagnostic implications. Acta Neurochir. 75 (1985) 49–59

    Google Scholar 

  24. Müller, O. A., G. K. Stalla, K. von Werder: Corticotrophin releasing factor: A new tool for the differential diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 57 (1983) 227–229

    PubMed  Google Scholar 

  25. Nakahara, M., T. Shibasaki, K. Shizume, Y. Kiyosawa, E. Odagiri, T. Suda, H. Yamaguchi, T. Tsushima, H. Demura, T. Maeda, I. Wakabayashi, N. Ling: Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitaryadrenal disorders. J. Clin. Endocrinol. Metab. 57 (1983) 963–968

    PubMed  Google Scholar 

  26. Orth, D. N., C. R. DeBold, G. S. DeCherney, R. V. Jackson, A. N. Alexander, J. Rivier, C. Rivier, J. Spiess, W. Vale: Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J. Clin. Endocrinol. Metab. 55 (1982) 1017–1019

    PubMed  Google Scholar 

  27. Orth, D. N., R. V. Jackson, G. S. DeCherney, C. R. DeBold, A. N. Alexander, D. P. Island, J. Rivier, C. Rivier, J. Spiess, W. Vale: Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J. Clin. Invest. 71 (1983) 587–595

    PubMed  Google Scholar 

  28. Pieters, G. F. F. M., A. R. M. M. Hermus, A. G. H. Smals, A. K. M. Bertelink, T. J. Benraad, P. W. C. Kloppenborg: Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease. J. Clin. Endocrinol. Metab. 57 (1983) 513–516

    PubMed  Google Scholar 

  29. Pieters, G. F. F. M., A. R. M. M. Hermus, A. G. H. Smals, P. W. C. Kloppenborg: Paradoxical responsiveness of growth hormone to corticotropinreleasing factor in acromegaly. J. Clin. Endocrinol. Metab. 58 (1984) 560–562

    PubMed  Google Scholar 

  30. Rivier, J., J. Spiess, M. O. Thorner, W. Vale: Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300 (1982) 276–278

    PubMed  Google Scholar 

  31. Rivier, C., W. Vale: Interaction of corticotropinreleasing factor and arginine vasopressin on adrenocorticotropin secretionin vivo. Endocrinology 113 (1983) 939–942

    PubMed  Google Scholar 

  32. Schulte, H. M., G. P. Chrousos, D. C. Chatterji, P. W. Gold, E. H. Oldfield, D. L. Loriaux: Safety of corticotropin-releasing factor. Lancet 1 (1983) 1222

    Google Scholar 

  33. Shibahara, S., Y. Morimoto, Y. Furutani, M. Notake, H. Takahashi, S. Shimizu, S. Horikawa, S. Numa: Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J. 2 (1983) 775–779

    PubMed  Google Scholar 

  34. Stalla, G. K., J. Hartwimmer, K. von Werder, O. A. Müller: Ovine (o) and human (h) corticotropin-releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol. (Copenh.) 106 (1984) 289–297

    Google Scholar 

  35. Thorner, M. O., R. L. Perryman, M. J. Cronin, A. D. Rogol, M. Draznin, A. Johanson, W. Vale, E. Horvath, K. Kovacs: Somatotroph hyperplasia: Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J. Clin. Invest. 70 (1982) 965–977

    PubMed  Google Scholar 

  36. Thorner, M. O., J. Spiess, M. L. Vance, A. D. Rogol, D. L. Kaiser, J. D. Webster, J. Rivier, J. L. Borges, S. R. Bloom, M. J. Cronin, W. S. Evans, R. M. MacLeod, W. Vale: Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1 (1983) 24–28

    PubMed  Google Scholar 

  37. Tsukada, T., Y. Nakai, T. Koh, S. Tsujii, H. Imura: Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening. J. Clin. Endocrinol. Metab. 57 (1983) 869–871

    PubMed  Google Scholar 

  38. Tsukada, T., Y. Nakai, T. Koh, S. Tsujii, M. Inada, M. Nishakawa, H. Shinoda, I. Kawai, N. Takezawa, H. Imura: Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders. J. Clin. Endocrinol. Metab. 58 (1984) 758–760

    PubMed  Google Scholar 

  39. Vale, W., J. Spiess, C. Rivier, J. Rivier: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394–1397

    PubMed  Google Scholar 

  40. Vale, W., C. Rivier, M. R. Brown, J. Spiess, G. Koob, L. Swanson, L. Bilezikjian, F. Bloom, J. Rivier: Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 39 (1983) 245–270

    PubMed  Google Scholar 

  41. Webb, C. B., M. L. Vance, M. O. Thorner, G. Perisutti, J. Thominet, J. Rivier, W. Vale, L. A. Frohman: Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Clin. Invest. 74 (1984) 96–103

    Google Scholar 

  42. von Werder, K., M. Losa, G. K. Stalla, L. Bock, O. A. Müller: Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF1−44. Acta Neurochir. 75 (1985) 81–87

    Google Scholar 

  43. von Werder, K., O. A. Müller, R. Hartl, M. Losa, G. K. Stalla: Growth hormone-releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients. J. Endocrinol. Invest. 7 (1984) 232–238

    Google Scholar 

  44. Wood, S. M., J. C. L. Ch'ng, E. F. Adams, J. D. Webster, G. F. Joplin, K. Mashiter, S. R. Bloom: Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF(1–44)) in acromegaly and hypopituitarism. Br. Med. J. 286 (1983) 1687–1691

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik Innenstadt, University of Munich, Ziemssenstraße 1, 8000, München 2, Germany

    Klaus von Werder & Otto-Albrecht Müller

Authors
  1. Klaus von Werder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto-Albrecht Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Professor Dr. Dieter Seitz, Department of Neurology, AK St. Georg, Hamburg

Supported by Deutsche Forschungsgemeinschaft (We 439/4–1 and Mu 585/2–1)

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Werder, K., Müller, OA. Corticotropin- and growth hormone-releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases. Neurosurg. Rev. 8, 155–165 (1985). https://doi.org/10.1007/BF01815440

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01815440

Keywords

Search

Navigation